AstraZeneca Pharma India Q3 net profit declines 21 pc at Rs 21 cr

By: |
February 8, 2021 8:18 PM

The company had posted a net profit of Rs 26.70 crore for the corresponding period of the previous fiscal, AstraZeneca Pharma India said in a BSE filing.

AstraZenecaShares of AstraZeneca Pharma India closed at Rs 3,899.40 per scrip on BSE.

Drug firm AstraZeneca Pharma India on Monday reported a 21 per cent decline in net profit at Rs 21.05 crore for the quarter ended in December.

The company had posted a net profit of Rs 26.70 crore for the corresponding period of the previous fiscal, AstraZeneca Pharma India said in a BSE filing.

Revenue from operations of the company stood at Rs 200.25 crore for the quarter under consideration. It was Rs 223.86 crore for the same period a year ago, it added.

Shares of AstraZeneca Pharma India closed at Rs 3,899.40 per scrip on BSE, up 0.11 percent from its previous close.

Get live Stock Prices from BSE, NSE, US Market and latest NAV, portfolio of Mutual Funds, Check out latest IPO News, Best Performing IPOs, calculate your tax by Income Tax Calculator, know market’s Top Gainers, Top Losers & Best Equity Funds. Like us on Facebook and follow us on Twitter.

Financial Express is now on Telegram. Click here to join our channel and stay updated with the latest Biz news and updates.

Next Stories
1WhatsApp can tell on you without snooping
2Home Smart Home: Variety of products to offer
3Actively pursuing Airbus to begin manufacturing aeroplanes in India, says Piyush Goyal